Patients
RRMS, MS-related fatigue
RECRUITMENT, RELAPSING REMITTING MULTIPLE SCLEROSIS, MULTIPLE SCLEROSIS, SECONDARY
Recruitment and inclusion of participants took place between April 2018 and December 2021.Characteristics of the 126 participants with MS-related fatigue in the booster RCT.MS: multiple sclerosis; RCT: randomized clinical trial; EDSS: Expanded Disability Status Scale; RRMS: relapsing remitting multiple sclerosis; PPMS: primary progressive MS; SPMS: secondary progressive MS; CIS: Checklist Individual Strength; SIP: Sickness Impact Profile; SF36: short form 36; WSAS: Work and Social Adjustment Scale.The booster sessions were provided by the same therapist as the initial treatment. In total, 25 therapists from 14 participating rehabilitation centres and hospitals treated patients in the booster RCT.Considering the small attrition rate, no additional per protocol analyses were conducted.